Using Intuitive Machines Inc (LUNR) Stock as an income source, let’s make some money!
Cantor Fitzgerald raised the price target for the Intuitive Machines Inc (NASDAQ:LUNR) stock to “an Overweight”. The rating was released on May 19, 2023, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $35. Historical Earnings Surprises and Revenue Forecasts Profit is the […]
Despite the lack of deep value, there is something else: Cardlytics Inc (CDLX) Stock
Craig Hallum raised the price target for the Cardlytics Inc (NASDAQ:CDLX) stock from “a Hold” to “a Buy”. The rating was released on March 15, 2024, according to finviz. The research report from Wells Fargo has downgraded the stock from Equal Weight to Underweight, with a price target set at $13. The stock was downgraded […]
Is it possible to sustain this rally? Akebia Therapeutics Inc. (AKBA) Stock
BTIG Research raised the price target for the Akebia Therapeutics Inc. (NASDAQ:AKBA) stock to “a Buy”. The rating was released on November 29, 2023, according to finviz. The research report from Piper Sandler has upgraded the stock from Neutral to Overweight, with a price target set at $4. The stock was downgraded by Piper Sandler, […]
Don’t be afraid of Annexon Inc (ANNX) Stock despite uncertainty and doubt
JP Morgan raised the price target for the Annexon Inc (NASDAQ:ANNX) stock from “a Neutral” to “an Overweight”. The rating was released on March 01, 2024, according to finviz. We previously noted in another research note published on December 21, 2023 by BofA Securities that upgraded the stock from a Neutral to a Buy with […]
The performance of MSP Recovery Inc (LIFW) Stock has improved
Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock price to increase when earnings exceed market expectations and progressively decrease when earnings do not meet expectations. The firm reported an earnings per share (EPS) of -$0.19 […]
Mesoblast Ltd ADR (MESO) Stock is looking to regain its victory
Jefferies raised the price target for the Mesoblast Ltd ADR (NASDAQ:MESO) stock from “a Hold” to “a Buy”. The rating was released on August 31, 2023, according to finviz. The stock was downgraded by Piper Sandler, who disclosed in a research note on August 04, 2023, from Overweight to Neutral and set the price objective […]
Top-line Growth is Likely to Be Driven by Babcock & Wilcox Enterprises Inc (BW) Stock
Craig Hallum lowered the price target for the Babcock & Wilcox Enterprises Inc (NYSE:BW) stock from “a Buy” to “a Hold”. The rating was released on November 10, 2023, according to finviz. The research report from Lake Street has initiated the stock to Buy, with a price target set at $12. The stock was initiated […]
There is no better tap than FibroGen Inc (FGEN) Stock
BofA Securities lowered the price target for the FibroGen Inc (NASDAQ:FGEN) stock from “a Neutral” to “an Underperform”. The rating was released on August 08, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]
Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) Stock upgraded by Maxim Group
Maxim Group raised the price target for the Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) stock from “a Hold” to “a Buy”. The rating was released on February 04, 2021, according to finviz. The research report from Maxim Group has reiterated the stock to Buy, with a price target set at $6. The stock was reiterated by […]
Velo3D Inc (NYSE:VLD) Stock Reported EPS of -$0.1 in Last Quarter
Credit Suisse raised the price target for the Velo3D Inc (NYSE:VLD) stock to “a Neutral”. The rating was released on August 17, 2022, according to finviz. The research report from Needham has initiated the stock to Buy, with a price target set at $15. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical […]
